封面
市場調查報告書
商品編碼
1616303

2024 - 2032 年醫學樣本追蹤系統市場機會、成長促進因素、產業趨勢分析與預測

Medical Specimen Tracking Systems Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 100 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023 年,全球醫學樣本追蹤系統市場價值為 10 億美元,預計 2024 年至 2032 年複合年成長率為 11.2%。在醫療保健和實驗室環境中,精確的標本處理可確保可靠的診斷結果和病人安全。標本的錯誤識別、遺失或污染可能導致錯誤診斷、延遲治療和損害患者治療結果,這凸顯了強大的追蹤系統的重要性。無線射頻識別 (RFID) 和條碼系統等技術改進顯著增強了對樣本移動和狀態的即時監控。

例如,RFID 技術可以實現自動資料收集並減少手動輸入錯誤,從而提高樣本追蹤的準確性和可靠性。醫院和診斷實驗室擴大採用這些系統來簡化操作並最大限度地減少人為錯誤。例如,克利夫蘭診所使用 RFID 和條碼實施了複雜的樣本追蹤系統,減少了貼錯標籤的樣本並縮短了測試結果的周轉時間。軟體領域在 2023 年創造了超過 5.675 億美元的收入。

先進的軟體系統提供即時追蹤功能、與實驗室資訊系統 (LIS) 的資料整合以及詳細的報告功能,這對於確保樣本處理的準確性和完整性至關重要。醫療保健領域對監管合規性和品質保證的重視刺激了對滿足 FDA 和 CLIA 等監管機構制定的嚴格標準的複雜追蹤軟體的需求。 2023 年,病患檢測領域的產業佔有率超過 5.832 億美元。慢性病盛行率的上升、人口老化以及對常規和預防性護理的需求不斷成長推動了這一激增,因此需要準確、高效的標本處理。

市場範圍
開始年份 2023年
預測年份 2024-2032
起始值 10億美元
預測值 28億美元
複合年成長率 11.2%

例如,越來越多的糖尿病和癌症篩檢需要強大的樣本追蹤系統,以確保及時、準確的診斷結果。約翰霍普金斯醫院等醫療保健提供者已經實施了先進的追蹤系統來管理大量病患標本,最大限度地減少錯誤並提高工作流程效率。對患者安全和診斷準確性的關注推動了患者檢測領域的市場擴張。 2023年,北美醫學樣本追蹤系統市佔率為3.871億美元。

先進的醫療基礎設施、不斷成長的自動化需求以及嚴格的監管要求推動了北美市場的發展。該地區對病人安全和實驗室品質控制的重視推動了條碼和 RFID 系統等先進追蹤技術的採用。例如,梅奧診所和約翰霍普金斯醫院已經實施了先進的標本追蹤系統,以最大限度地減少錯誤並提高工作流程效率。由於慢性病盛行率上升和人口老化,診斷檢測量不斷增加,進一步推動了市場成長。

目錄

第 1 章:方法與範圍

第 2 章:執行摘要

第 3 章:產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 對準確、高效的樣本追蹤的需求不斷成長
      • 實驗室擴大採用自動化
      • 日益關注病患安全和監管合規性
      • 追蹤科技的進步
    • 產業陷阱與挑戰
      • 將追蹤系統與現有工作流程整合的複雜性
      • 發展中地區的認知有限
  • 成長潛力分析
  • 監管環境
  • 啟動場景
  • 技術景觀
  • 波特的分析
  • PESTEL分析
  • 未來市場趨勢
  • 差距分析

第 4 章:競爭格局

  • 介紹
  • 公司矩陣分析
  • 主要參與者的競爭分析
  • 競爭定位矩陣
  • 戰略儀表板

第 5 章:市場估計與預測:按產品分類,2021 - 2032 年

  • 主要趨勢
  • 軟體
  • 硬體
  • 耗材

第 6 章:市場估計與預測:按技術分類,2021 - 2032 年

  • 主要趨勢
  • 條碼
  • 射頻識別
  • 全球定位系統
  • 其他技術

第 7 章:市場估計與預測:按樣本類型,2021 - 2032 年

  • 主要趨勢
  • 患者測試
  • 臨床試驗測試
  • 其他標本類型

第 8 章:市場估計與預測:按最終用途,2021 - 2032 年

  • 主要趨勢
  • 醫院和診所
  • 病理實驗室
  • 其他最終用戶

第 9 章:市場估計與預測:按地區,2021 - 2032

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區

第 10 章:公司簡介

  • BioIT Solutions
  • Cryoport Systems, LLC
  • GAO Group
  • LabConnect
  • Laboratory Corporation of America Holdings.
  • LabWare
  • NovoPath
  • Quick International Courier
  • RMS Omega
  • STARLIMS Corporation
  • STORQ
  • Taylor Data Systems, Inc.
簡介目錄
Product Code: 11209

The Global Medical Specimen Tracking Systems Market was valued at USD 1 billion in 2023 and is projected to grow at a CAGR of 11.2% between 2024 and 2032. An increasing need for accurate and efficient specimen tracking drives this market. In healthcare and laboratory environments, precise specimen handling ensures reliable diagnostic results and patient safety. Misidentification, loss, or contamination of specimens can lead to incorrect diagnoses, delayed treatments, and compromised patient outcomes, underscoring the importance of robust tracking systems. Technological improvements, such as Radio Frequency Identification (RFID) and barcode systems, have significantly enhanced real-time monitoring of specimen movement and status.

RFID technology, for instance, allows automated data capture and reduces manual entry errors, improving the accuracy and reliability of specimen tracking. Hospitals and diagnostic laboratories are increasingly adopting these systems to streamline operations and minimize human error. Cleveland Clinic, for example, implemented a sophisticated specimen tracking system using RFID and barcodes, which has reduced mislabeled specimens and improved test result turnaround times. The software segment generated more than USD 567.5 million in 2023. The adoption of automation in laboratories and healthcare facilities is a major driver, as software solutions streamline specimen tracking processes, reduce human error, and enhance workflow efficiency.

Advanced software systems offer real-time tracking capabilities, data integration with laboratory information systems (LIS), and detailed reporting features, which are crucial for ensuring the accuracy and integrity of specimen handling. The emphasis on regulatory compliance and quality assurance in healthcare has fueled demand for sophisticated tracking software that meets stringent standards set by regulatory bodies like the FDA and CLIA. The industry share from the patient testing segment was over USD 583.2 million in 2023. This segment dominates the market due to the increasing volume of diagnostic tests performed in hospitals, clinics, and laboratories. The rising prevalence of chronic diseases, aging populations, and the growing demand for routine and preventive care drive this surge, necessitating accurate and efficient specimen handling.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$1 Billion
Forecast Value$2.8 Billion
CAGR11.2%

For instance, the increasing number of diabetes and cancer screenings requires robust specimen tracking systems to ensure timely and precise diagnostic outcomes. Healthcare providers, such as Johns Hopkins Hospital, have implemented advanced tracking systems to manage the high volume of patient specimens, minimizing errors and enhancing workflow efficiency. This focus on patient safety and diagnostic accuracy drives the expansion of the patient testing segment in the market. In 2023, the North America medical specimen tracking systems market share accounted for USD 387.1 million in.

Advanced healthcare infrastructure, increasing demand for automation, and stringent regulatory requirements drive the North American market. The region's emphasis on patient safety and quality control in laboratories propels the adoption of sophisticated tracking technologies such as barcodes and RFID systems. For example, the Mayo Clinic and Johns Hopkins Hospital have implemented advanced specimen tracking systems to minimize errors and enhance workflow efficiency. The growing volume of diagnostic testing due to the rising prevalence of chronic diseases and the aging population further fuels market growth.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing demand for accurate and efficient specimen tracking
      • 3.2.1.2 Growing adoption of automation in laboratories
      • 3.2.1.3 Rising focus on patient safety and regulatory compliance
      • 3.2.1.4 Advancements in tracking technologies
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Complexity in integrating tracking systems with existing workflow
      • 3.2.2.2 Limited awareness in developing regions
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Start-up scenarios
  • 3.6 Technology landscape
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis
  • 3.9 Future market trends
  • 3.10 Gap analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Competitive analysis of major key players
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Software
  • 5.3 Hardware
  • 5.4 Consumables

Chapter 6 Market Estimates and Forecast, By Technology, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Barcode
  • 6.3 RFID
  • 6.4 GPS
  • 6.5 Other technologies

Chapter 7 Market Estimates and Forecast, By Specimen Type, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Patient testing
  • 7.3 Clinical trial testing
  • 7.4 Other specimen types

Chapter 8 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals & clinics
  • 8.3 Pathology labs
  • 8.4 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
    • 9.3.7 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
    • 9.5.4 Rest of Latin America
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE
    • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

  • 10.1 BioIT Solutions
  • 10.2 Cryoport Systems, LLC
  • 10.3 GAO Group
  • 10.4 LabConnect
  • 10.5 Laboratory Corporation of America Holdings.
  • 10.6 LabWare
  • 10.7 NovoPath
  • 10.8 Quick International Courier
  • 10.9 RMS Omega
  • 10.10 STARLIMS Corporation
  • 10.11 STORQ
  • 10.12 Taylor Data Systems, Inc.